Xenon to Present at Upcoming Investor Conferences GlobeNewswire November 06, 2025 VANCOUVER, British Columbia and BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced that the Company will present at two […]
KraneShares Humanoid Robotics ETF (Ticker: KOID) Approved On Stifel Platform GlobeNewswire November 06, 2025 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — KraneShares, a leading provider of exchange-traded funds (ETFs) delivering access to emerging technologies and innovative global asset classes, today announced that the KraneShares Global Humanoid and Embodied Intelligence Index ETF (Ticker: KOID) has
RenovoRx Strengthens Scientific Advisory Board (SAB) with Pancreatic Cancer Expert Timothy Donahue, MD Company Appoints Distinguished UCLA Oncology Surgeon to SAB, Enhancing Board's Expertise in Surgical Oncology and Translational Oncology Research Aimed at Improving Multidisciplinary Treatment Strategies GlobeNewswire November 06, 2025 MOUNTAIN VIEW, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — RenovoRx, Inc. (“RenovoRx” or the
Bath & Body Works to Report Third Quarter Results on November 20, 2025 GlobeNewswire November 06, 2025 COLUMBUS, Ohio, Nov. 06, 2025 (GLOBE NEWSWIRE) — Bath & Body Works, Inc. (NYSE: BBWI) announced today that it plans to report its third quarter 2025 financial results before market open on Thursday, November 20, 2025. In conjunction
zSpace Expands Global Footprint with AI-Powered Inspire 2 AR/VR Laptop Launch at GESS Dubai 2025 Headset-Free Immersive Learning Brings the Future of Education to Classrooms Across the Middle East, Supported by AI-Driven Language Accessibility GlobeNewswire November 06, 2025 SAN JOSE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — zSpace, Inc. (NASDAQ: ZSPC), a global leader in
First Financial Corporation and CedarStone Financial, Inc. Sign Merger Agreement GlobeNewswire November 06, 2025 TERRE HAUTE, Ind. and LEBANON, Tenn., Nov. 06, 2025 (GLOBE NEWSWIRE) — First Financial Corporation (NASDAQ: THFF) (“First Financial”) and CedarStone Financial, Inc. (“CedarStone”) jointly announced today the execution of a definitive agreement under which First Financial will acquire CedarStone. First
Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results GlobeNewswire November 06, 2025 – Private Placement Financing of Up to $105.3 Million Closed in October 2025 to Fund Operations and R&D – Sally Lawlor Appointed CFO to Support Commercialization and Financial Operations – Orphan Drug Designation Awarded by FDA to QRX003 for Netherton
PolyPid's D-PLEXâ‚₀₀ Wins BioTech Breakthrough Award for “Therapeutics Solution of the Year” PolyPid's Lead Candidate Recognized for Addressing Critical Unmet Need in Surgical Site Infection Prevention Following Positive Phase 3 Results GlobeNewswire November 06, 2025 PETACH TIKVA, Israel, Nov. 06, 2025 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma
Runway Growth Finance Corp. Announces Fourth Quarter 2025 Dividend of $0.33 per Share GlobeNewswire November 06, 2025 MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity,
Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 06, 2025 Submitted a New Drug Application (NDA) for accelerated approval of bitopertin in erythropoietic protoporphyria (EPP) on September 29, 2025; Awarded the FDA Commissioner's National Priority Voucher (CNPV), which is designed to shorten the expected NDA review period to 1-2